NCT06125275 is a clinical trial in Antipsychotic Drug- Toxicity, sponsored by Assiut University.

Who is sponsoring NCT06125275?

NCT06125275 is sponsored by Assiut University.

What condition does NCT06125275 study?

NCT06125275 studies Antipsychotic Drug- Toxicity.

Is NCT06125275 still recruiting?

NCT06125275 is currently status unknown. Last updated 9 November 2023.

Last reviewed 2023-11-09 · How we verify

NCT06125275

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pattern of Acute Antipsychotic Drug- Toxicity in Children

Status unknown Last updated 9 November 2023

What this trial tests

trial in Antipsychotic Drug- Toxicity in 50 participants. Status unknown.

Timeline

30 October 2023

Primary endpoint
31 December 2025

28 February 2026

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	50
Start date	30 October 2023
Primary completion	31 December 2025
Estimated completion	28 February 2026

Conditions studied

Antipsychotic Drug- Toxicity — all drugs for Antipsychotic Drug- Toxicity →

Sponsor

Assiut University

Who can join

Adults 1 Month to 18, any sex, with Antipsychotic Drug- Toxicity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pattern of Acute Antipsychotic Drug- Toxicity in Children at Assiut University Children Hospital. * Determine the pattern and outcome of acute antipsychotic drug- toxicity of children who are admitted to The emergency department of Assiut University Children Hospital (AUCH). * Estimate prevalence of acute antipsychotics drug-toxicity in children and adolescents at AUCH.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06125275 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 9 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06125275.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing